These patients require careful monitoring if interferon is considered the first line of treatment. Rejection may occur if interferon is used after liver transplantation. A variety of rashes including erythema multiforme have been noted. Pruritus can be troublesome. Mild hair loss is relatively common but is reversible.
Local erythema is common.
Psoriasis can develop de novo, or be aggravated, and is usually difficult to treat. Vitiligo has been reported. Myelosuppression Granulocytes, thrombocytes, and red blood cell counts are commonly decreased during treatment. These are usually mild if normal counts are present initially, but can be dose limiting in the presence of low counts, for example in patients with hypersplenism. Patients may be predisposed to infections.